Largest ever Parkinson’s research trial is starting now
Date
Research news
Date
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
Date
New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
Date
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Date
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Date
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
Date
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
Date
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
Date
An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
Date
New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
Date
We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.